Saturday, January 28, 2017

It's always about the profits and investors

Great article explaining the high price of pharmaceuticals in the US compared to other countries and how it affects the industry.


"The United States is exceptional in that it does not regulate or negotiate the prices of new prescription drugs when they come onto market. Other countries will task a government agency to meet with pharmaceutical companies and haggle over an appropriate price. These agencies will typically make decisions about whether these new drugs represent any improvement over the old drugs — whether they’re even worth bringing onto the market in the first place. They’ll pore over reams of evidence about drugs’ risks and benefits.

The United States allows drug makers to set their own prices for a given product — and allows every drug that's proven to be safe come onto market. And the problems that causes are easy to see, from the high co-pays at the drugstore to the people who can’t afford lifesaving medications."

No comments: